165 related articles for article (PubMed ID: 10549712)
1. Structural characterization of low molecular weight heparins.
Casu B; Torri G
Semin Thromb Hemost; 1999; 25 Suppl 3():17-25. PubMed ID: 10549712
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy.
Guerrini M; Guglieri S; Naggi A; Sasisekharan R; Torri G
Semin Thromb Hemost; 2007 Jul; 33(5):478-87. PubMed ID: 17629844
[TBL] [Abstract][Full Text] [Related]
3. Structural modification induced in heparin by a Fenton-type depolymerization process.
Vismara E; Pierini M; Guglieri S; Liverani L; Mascellani G; Torri G
Semin Thromb Hemost; 2007 Jul; 33(5):466-77. PubMed ID: 17629843
[TBL] [Abstract][Full Text] [Related]
4. Variability of heparins and heterogeneity of low molecular weight heparins.
Bianchini P; Liverani L; Spelta F; Mascellani G; Parma B
Semin Thromb Hemost; 2007 Jul; 33(5):496-502. PubMed ID: 17629846
[TBL] [Abstract][Full Text] [Related]
5. Preserving the original heparin structure of a novel low molecular weight heparin by gamma-irradiation.
Bisio A; De Ambrosi L; Gonella S; Guerrini M; Guglieri S; Maggia G; Torri G
Arzneimittelforschung; 2001 Oct; 51(10):806-13. PubMed ID: 11715633
[TBL] [Abstract][Full Text] [Related]
6. Production and chemical processing of low molecular weight heparins.
Linhardt RJ; Gunay NS
Semin Thromb Hemost; 1999; 25 Suppl 3():5-16. PubMed ID: 10549711
[TBL] [Abstract][Full Text] [Related]
7. Generic low-molecular-weight heparins: some practical considerations.
Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
[TBL] [Abstract][Full Text] [Related]
8. Combined quantitative (1)H and (13)C nuclear magnetic resonance spectroscopy for characterization of heparin preparations.
Guerrini M; Bisio A; Torri G
Semin Thromb Hemost; 2001 Oct; 27(5):473-82. PubMed ID: 11668416
[TBL] [Abstract][Full Text] [Related]
9. Characterization of sulfation patterns of beef and pig mucosal heparins by nuclear magnetic resonance spectroscopy.
Casu B; Guerrini M; Naggi A; Torri G; De-Ambrosi L; Boveri G; Gonella S; Cedro A; Ferró L; Lanzarotti E; Paterno M; Attolini M; Valle MG
Arzneimittelforschung; 1996 May; 46(5):472-7. PubMed ID: 8737629
[TBL] [Abstract][Full Text] [Related]
10. Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1,6-anhydro-beta-D-glucosamine or N-sulfated 1,6-anhydro-beta-D-mannosamine residues.
Mascellani G; Guerrini M; Torri G; Liverani L; Spelta F; Bianchini P
Carbohydr Res; 2007 May; 342(6):835-42. PubMed ID: 17280651
[TBL] [Abstract][Full Text] [Related]
11. Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
Bisio A; Vecchietti D; Citterio L; Guerrini M; Raman R; Bertini S; Eisele G; Naggi A; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):865-73. PubMed ID: 19888521
[TBL] [Abstract][Full Text] [Related]
12. Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patterns.
Sissi C; Naggi A; Torri G; Palumbo M
Semin Thromb Hemost; 2003 Dec; 29(6):661-70. PubMed ID: 14719183
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparins: differential characterization/physical characterization.
Guerrini M; Bisio A
Handb Exp Pharmacol; 2012; (207):127-57. PubMed ID: 22566224
[TBL] [Abstract][Full Text] [Related]
14. Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human Cathepsin G.
Sissi C; Lucatello L; Naggi A; Torri G; Palumbo M
Biochem Pharmacol; 2006 Jan; 71(3):287-93. PubMed ID: 16310171
[TBL] [Abstract][Full Text] [Related]
15. Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.
Alekseeva A; Casu B; Cassinelli G; Guerrini M; Torri G; Naggi A
Anal Bioanal Chem; 2014 Jan; 406(1):249-65. PubMed ID: 24253408
[TBL] [Abstract][Full Text] [Related]
16. An assessment of polydispersed species in unfractionated and low molecular weight heparins by diffusion ordered nuclear magnetic resonance spectroscopy method.
Bednarek E; Sitkowski J; Bocian W; Mulloy B; Kozerski L
J Pharm Biomed Anal; 2010 Nov; 53(3):302-8. PubMed ID: 20417048
[TBL] [Abstract][Full Text] [Related]
17. Structural features and bleeding activity of commercial low molecular weight heparins: neutralization by ATP and protamine.
Dietrich CP; Shinjo SK; Moraes FA; Castro RA; Mendes A; Gouvea TC; Nader HB
Semin Thromb Hemost; 1999; 25 Suppl 3():43-50. PubMed ID: 10549715
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry.
Camara JE; Satterfield MB; Nelson BC
J Pharm Biomed Anal; 2007 Apr; 43(5):1706-14. PubMed ID: 17275239
[TBL] [Abstract][Full Text] [Related]
19. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
